Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3046299	s-parprot	— (—)	288	1578	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Primary_lymphoid and hematopoietic malignant neoplasms

156

42.79

261.16

8.8

1.5

—

Multiple myeloma and malignant plasma cell neoplasms

133

96.37

255.30

9.8

1.6

—

Primary_lymphoid and hematopoietic malignant neoplasms

156

36.80

251.22

8.8

1.4

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

185

218.70

180.31

7.7

1.0

—

Transplanted organ and tissue status

80.61

148.14

9.9

2.4

—

Multiple myeloma, excluding all cancers (controls excluding all cancers)

135

209.71

131.77

9.7

1.1

—

Multiple myeloma and malignant plasma cell neoplasms

133

206.49

129.69

9.8

1.1

—

ILD medications: immunosuppressive drugs

119

12.72

120.03

9.5

2.8

—

L04AX Other immunosuppressants

110

100

11.04

103.73

10.1

2.8

—

Second line medication for Crohn's disease

110

102

10.82

102.36

10.1

2.8

—

Multiple myeloma

134.93

91.05

10.4

3.3

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

134.93

91.05

10.4

3.3

—

Bacterial infection, other or unspecified

124

6.78

57.23

7.2

3.8

—

First line medication for Crohn's disease

105

6.03

46.08

6.8

2.0

—

Other bacterial diseases

111

155

4.96

44.98

7.0

4.3

—

Malignant neoplasm

6.44

43.61

7.0

1.6

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

105

140

5.10

43.58

7.8

4.1

—

ILD medications

109

114

5.25

42.30

7.1

2.7

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

107

173

4.44

38.87

5.2

5.6

—

Renal failure

124

5.54

38.20

6.0

5.0

—

Oxycodone

6.33

38.09

9.0

3.3

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

5.99

36.43

7.1

1.6

—

Malignant neoplasm, wide definition for exclusion

5.99

36.43

7.1

1.6

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

5.99

36.43

7.2

1.6

—

Bacterial Sepsis

121

5.08

31.77

6.4

4.6

—

Pneumonia, organism unspecified

160

4.12

30.36

8.0

3.8

—

Any event in cancer register

102

4.71

29.29

6.8

2.8

—

Implicit bacterial Sepsis

116

4.99

28.75

5.8

4.7

—

Renal tubulo-interstitial diseases

182

3.80

27.57

5.6

5.5

—

Aplastic and other anaemias

136

4.54

26.87

5.5

5.4

—

Fever of other and unknown origin

125

4.68

26.82

9.0

4.6

—

Acute renal failure

7.25

26.67

7.1

3.6

—

Other and unspecified anaemias

123

4.73

26.22

5.7

—

Other anaemias

123

4.72

26.12

5.7

—

Medical observation and evaluation for suspected diseases and conditions

5.38

25.08

5.4

4.1

—

Influenza and pneumonia

165

3.63

24.92

8.3

3.8

—

Pneumonias (Asthma/COPD co-morbidities)

170

3.63

24.83

8.2

3.8

—

Implicit Sepsis

164

3.80

24.67

5.7

4.6

—

All pneumoniae

170

3.62

24.67

8.2

3.9

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

174

3.56

23.98

8.0

4.0

—

133

3.82

23.39

8.4

3.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

133

3.82

23.39

8.4

3.1

—

Chronic kidney disease

5.30

21.63

5.2

—

Persons encountering health services for specific procedures and health care

172

3.28

21.16

6.5

4.6

—

Neoplasms

7.15

20.08

4.7

1.5

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

+∞

19.00

5.3

0.0

—

Malignant immunoproliferative diseases

+∞

18.94

5.3

0.0

—

Diseases of pulp and periapical tissues

5.14

18.57

7.2

4.4

—

Condition for Implicit Sepsis (Organ dysfunction codes)

171

3.23

18.25

5.4

4.9

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

8.57

18.01

4.9

4.8

—

Chronic periapical parodontitis

6.32

17.52

8.0

5.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

114

3.47

17.21

5.5

2.7

—

Septicaemia

104

4.07

16.05

9.1

3.8

—

Gout, FINNGEN

4.18

15.25

4.8

5.4

—

Anaemias

25.51

15.00

5.7

1.7

—

Infections, IBD-co-morbidities

10.66

14.71

4.8

6.3

—

All influenza

5.29

14.15

12.9

2.7

—

Gout

4.02

14.12

4.8

5.8

—

Other septicaemia

4.02

13.72

9.6

4.0

—

Dental caries

5.25

13.50

5.3

4.7

—

Explicit Sepsis

120

3.52

13.13

9.1

4.6

—

Dentinal caries

5.42

12.94

5.5

4.2

—

Disorders of calcium metabolism

9.43

12.55

8.3

4.4

—

COPD/asthma/ILD related infections

133

2.79

12.50

7.6

3.1

—

COPD/asthma related infections

133

2.79

12.50

7.6

3.1

—

Osteopathies and chondropathies

159

3.05

12.09

5.6

5.8

—

Unspecified kidney failure

7.42

11.84

4.5

3.1

—

Polyarthropathies

145

2.81

11.46

4.2

6.0

—

Heart failure, not strict

171

2.66

11.37

5.0

5.8

—

Chronic periodontitis

5.90

11.31

6.4

4.4

—

Deposits [accretions] on teeth

19.41

10.91

7.3

6.5

—

General symptoms and signs

144

2.58

10.90

6.4

4.7

—

Fitting and adjustment of other devices

117

3.26

10.87

6.2

4.5

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

202

2.66

10.77

5.3

5.6

—

Disorders of mineral metabolism

7.53

10.56

8.3

4.1

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

+∞

10.56

5.5

0.0

—

Oedema, not elsewhere classified

3.81

10.53

4.9

5.0

—

GASTRO-related operations

3.76

10.34

4.6

4.8

—

Any gastric operation

3.76

10.34

4.6

4.8

—

Bronchitis

210

2.37

10.30

9.6

4.0

—

Glomerular diseases

4.90

10.24

5.0

4.8

—

Streptococcal septicaemia

7.81

10.14

6.9

2.2

—

Explicit bacterial Sepsis

7.16

10.12

8.5

2.3

—

Other disorders of teeth and supporting structures

4.45

10.00

6.7

4.3

—

185

2.31

9.79

9.1

4.0

—

Dyspnoea

213

2.41

9.77

5.4

5.5

—

Abnormal findings on diagnostic imaging of lung

153

2.87

9.73

4.9

5.4

—

Fentanyl

6.17

9.44

15.6

2.4

—

Constipation

206

2.37

9.39

7.2

4.7

—

Abnormalities of breathing

139

2.57

9.32

4.9

5.4

—

Other and unspecified disorders of skin and subcutaneous tissue

7.68

9.28

7.4

5.6

—

Iron deficiency anaemia

123

3.06

9.27

3.5

6.0

—

Glomerular disorders in diseases classified elsewhere

5.68

9.27

5.5

4.8

—

Follow-up examination after treatment for conditions other than malignant neoplasms

3.96

9.12

5.6

4.1

—

Implicit viral Sepsis

4.57

9.04

7.1

3.6

—

Viral Sepsis

4.57

9.04

7.1

3.6

—

Care involving dialysis

7.25

8.84

8.1

4.2

—

Nutritional anaemias

146

2.80

8.75

3.3

5.7

—

Gout, unspecified

3.88

8.40

4.7

5.1

—

Viral pneumonia

5.78

8.32

14.1

3.1

—

Acute upper respiratory infections of multiple and unspecified sites

142

2.59

8.28

11.1

4.0

—

Certain infectious and parasitic diseases

113

2.53

8.20

6.5

3.8

—

Other pulmonary diagnosis

2.77

8.01

6.3

3.1

—

L01XX Other antineoplastic agents

5.87

7.85

15.8

3.6

—

Dialysis, with operation codes

5.85

7.85

7.6

3.9

—

Other heart diseases, wide

138

2.43

7.68

5.9

6.3

—

Factors influencing health status and contact with health services

5.28

7.67

5.3

2.6

—

Gout, idiopatic and unspecified

3.34

7.63

4.4

4.7

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

4.73

7.63

5.9

4.7

—

Diseases of external ear

3.16

7.51

4.7

5.9

—

Impacted cerumen

5.19

7.44

4.4

—

Unspecified haematuria

115

2.76

7.34

5.1

5.6

—

Senile cataract

126

2.46

7.33

6.5

5.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

3.02

7.32

5.7

4.1

—

Other systemic involvement of connective tissue

3.22

7.22

6.0

5.8

—

Disorders of lens

130

2.43

7.16

5.6

4.9

—

Excluding asthma or asthma-COPD overlap

2.65

7.14

6.5

3.1

—

Other diseases of hard tissues of teeth

117

2.61

7.11

4.6

4.9

—

Systemic connective tissue disorders

106

2.93

7.09

5.5

5.7

—

Other heart diseases

3.43

7.09

5.9

5.5

—

Other acute lower respiratory infections

150

2.55

6.98

9.1

4.8

—

Oral corticosteroids

200

2.09

6.94

5.4

5.6

—

Other and unspecified iron deficiency

3.01

6.74

4.0

6.1

—

Presence of other functional implants

118

2.52

6.73

6.8

4.3

—

Autoimmune diseases excluding thyroid diseases, strict definition

167

2.14

6.68

4.6

6.1

—

Autoimmune diseases excluding thyroid diseases

174

2.11

6.65

4.5

6.0

—

Other systemic involvement of connective tissue (FG)

3.27

6.59

4.0

5.9

—

Other diseases of intestines

169

2.13

6.54

5.9

5.3

—

General examination and investigation of persons without complaint and reported diagnosis

2.92

6.52

5.1

4.1

—

COPD differential diagnosis

2.56

6.45

6.7

3.1

—

ILD differential diagnosis

2.56

6.45

6.7

3.1

—

Opioids

128

2.26

6.44

7.2

3.5

—

Extracorporeal dialysis

6.14

6.43

9.4

5.1

—

Spondylopathies in diseases classified elsewhere

14.60

6.42

12.8

4.1

—

Acute upper respiratory infections

206

2.04

6.42

9.4

4.1

—

Amyloidosis

14.46

6.41

4.8

4.0

—

Erysipelas

133

2.54

6.39

6.4

3.8

—

Continuous positive airway pressure

3.56

6.31

4.2

5.9

—

Asthma, unspecified (mode)

2.87

6.29

7.1

3.1

—

Persons encountering health services for examination and investigation

2.83

6.26

4.1

—

Other diseases of pleura

142

2.44

6.15

3.2

5.7

—

Gastro-oesophageal reflux disease

192

2.22

6.13

5.9

6.0

—

Symptoms and signs involving the urinary system

201

2.12

6.11

5.0

5.7

—

Malaise and fatigue

114

2.56

6.04

7.7

4.7

—

Missing teeth due to accident, extraction or parodontitis

5.23

6.00

5.8

4.3

—

Iron deficiency anaemia secondary to blood loss (chronic)

3.87

5.98

3.2

4.7

—

All influenza (not pneumonia)

4.82

5.96

12.6

3.1

—

Respiratory insufficiency

6.25

5.94

1.6

3.6

—

Atrial fibrillation and flutter

3.27

5.88

5.5

5.4

—

Non-ischemic cardiomyopathy

102

2.58

5.60

3.5

6.0

—

Sicca syndrome [Sjögren]

5.25

5.52

2.4

5.4

—

Other pleural conditions

4.49

5.50

2.8

3.9

—

Inflammatory bowel disease treatment related agents

201

1.92

5.49

4.9

5.6

—

Tramadol

127

2.23

5.35

9.3

3.5

—

Benign neoplasm of colon, rectum, anus and anal canal

2.80

5.32

5.7

1.5

—

Benign neoplasms

2.83

5.26

4.9

1.6

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

5.01

5.26

3.8

1.2

—

Chronic periodontitis, complicated

4.63

5.25

5.8

4.5

—

Other and unspecified polyneuropathies, also in other diseases

3.17

5.03

5.7

3.8

—

Diverticular disease of intestine

158

2.06

4.99

5.6

5.3

—

Diseases of the respiratory system

2.41

4.98

5.3

3.2

—

Gastrointestinal diseases

2.74

4.98

4.8

5.1

—

Abnormal findings on examination of blood, without diagnosis

156

2.22

4.88

4.5

5.2

—

Acute sinusitis

2.57

4.87

10.1

4.1

—

Diseases of oesophagus, stomach and duodenum

201

1.87

4.78

5.2

5.8

—

Osteonecrosis

5.02

4.78

6.9

5.3

—

Any reimbursement code in KELA

3.53

4.76

6.1

1.9

—

Other bacterial intestinal infections

3.41

4.74

8.9

4.1

—

Polyneuropathies and other disorders of the peripheral nervous system

2.95

4.70

6.8

4.3

—

Other arthritis (FG)

2.84

4.64

4.6

6.7

—

Other disorders of bone

3.69

4.64

8.7

5.1

—

Other functional intestinal disorders

121

2.36

4.58

4.8

5.2

—

Nausea and vomiting

2.74

4.55

7.3

5.4

—

Other diseases of blood and blood-forming organs, wide

2.97

4.54

9.5

5.5

—

Metabolic disorders

184

1.89

4.48

5.4

5.1

—

Disorders of eyelid, lacrimal system and orbit

225

1.88

4.48

6.6

5.2

—

Asthma, unspecified (mode), excluding more controls

2.58

4.41

7.0

3.3

—

Osteoporosis

2.57

4.39

3.5

6.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

2.55

4.32

5.9

1.5

—

Examination and observation for other reasons

2.59

4.32

8.8

4.1

—

Viral pneumonia (known virus, not influenza)

11.75

4.28

12.6

5.0

—

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

11.72

4.28

4.3

1.2

—

Parasetamol

2.22

4.27

4.6

4.3

—

Benign neoplasm: Colon

2.63

4.19

6.1

1.6

—

Acute suppurative otitis media

4.45

4.11

8.5

3.5

—

Acute tubulo-interstitial nephritis

147

2.11

4.10

4.5

5.7

—

Nephropathy related operations

3.76

4.08

8.7

4.4

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2.47

4.07

5.6

1.5

—

Fracture of lumbar spine and pelvis

2.70

4.06

4.6

5.7

—

Urticaria and erythema

2.63

4.05

6.7

6.0

—

Bacterial intestinal infections, IBD co-morbidities

3.20

4.05

7.5

4.7

—

Polyuria

2.93

4.00

2.5

5.6

—

Acute bronchitis

127

2.24

3.98

9.9

4.8

—

Codes for special purposes

2.43

3.95

4.3

5.6

—

Provisional assignment of new diseases of uncertain etiology

2.43

3.95

4.3

5.6

—

Diseases of oral cavity, salivary glands and jaws

146

1.86

3.92

5.9

5.0

—

Other diseases of lip and oral mucosa

3.64

3.92

4.4

—

Presence of other devices

2.88

3.88

4.1

4.6

—

Fissure and fistula of anal and rectal regions

2.97

3.84

4.6

4.4

—

Symptoms and signs involving the circulatory and respiratory systems

140

1.86

3.83

5.8

5.4

—

Neurological diseases, wide definition

4.30

3.81

3.3

6.3

—

Unspecified acute lower respiratory infection

3.80

7.3

3.3

—

Disorders of choroid and retina

215

1.80

3.80

5.9

5.3

—

Drug-induced cataract

8.81

3.78

9.4

4.4

—

Codeine

128

1.93

3.78

5.9

3.5

—

Haemolytic anaemias

8.79

3.77

3.4

7.4

—

Injuries to the thorax

140

2.14

3.75

7.8

4.9

—

Other disorders of fluid, electrolyte and acid-base balance

2.41

3.73

7.0

4.7

—

Direct fill therapy

4.00

3.69

5.3

4.6

—

Autoimmune diseases

175

1.75

3.67

4.2

6.0

—

Covid-19 confirmed case

2.69

3.64

5.2

4.7

—

Haemorrhoids and perianal venous thrombosis

2.42

3.62

3.9

5.1

—

Impacted teeth

8.15

3.59

4.3

3.5

—

Pneumococcal septicemia

7.81

3.56

8.3

7.0

—

Secondary hypertension

7.72

3.53

2.7

7.1

—

Other diseases of anus and rectum

2.44

3.53

6.1

5.0

—

Acquired haemolytic anaemia

10.06

3.50

3.8

9.5

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

2.37

3.49

7.0

1.5

—

Benign neoplasm: Colon, unspecified

3.03

3.49

5.6

1.4

—

Embedded and impacted teeth

5.47

3.49

4.7

3.1

—

Heart failure,strict

136

1.96

3.48

4.1

5.9

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

3.55

3.47

6.5

1.2

—

AV-block

3.03

3.42

2.1

6.0

—

Urticaria

2.76

3.41

6.8

6.2

—

Gout, strict definition

2.66

3.39

3.8

4.6

—

COPD (mode)

2.56

3.35

4.8

3.3

—

Finngen Rheumatological endpoints

152

1.80

3.34

3.6

5.8

—

Other/unspecified rheumatoid arthritis

3.25

3.34

2.2

5.8

—

Low back pain

165

1.87

3.32

7.4

4.8

—

Genitourinary diseases

2.23

3.30

4.9

4.4

—

Other disorders of skin and subcutaneous tissue

212

1.82

3.29

5.3

5.8

—

Lymphoid leukaemia

8.59

3.26

10.2

1.1

—

Cough

2.25

3.24

5.5

6.2

—

Heart failure and antihypertensive medication

2.44

3.22

5.3

7.2

—

Infections of the skin and subcutaneous tissue

142

2.03

3.21

8.3

4.9

—

Cardiac arrhythmias

105

2.01

3.19

5.4

6.2

—

Other soft tissue disorders, not elsewhere classified

182

1.73

3.19

6.1

5.4

—

Other diseases of jaws

6.38

3.18

10.6

5.0

—

Other (seronegative) rheumatoid arthritis, wide

2.73

3.15

2.1

6.1

—

Other reaction to severe stress, and adjustment disorders

2.73

3.15

7.5

6.0

—

Other/unspecified dorsalgia

110

2.17

3.14

8.0

5.1

—

Hypo-osmolality and hyponatraemia

2.72

3.13

8.2

5.1

—

Other specified/unspecified arthritis

2.41

3.13

4.9

6.4

—

Use of hypnotics and sedatives

197

1.67

3.13

7.8

4.5

—

Later onset COPD, excluding more controls

2.79

3.09

5.6

3.4

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

2.26

3.07

6.0

1.5

—

Purpura and other haemorrhagic conditions

3.24

3.05

8.5

3.9

—

DVT of lower extremities

2.68

3.05

7.1

5.7

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

3.49

3.05

2.9

1.3

—

Agranulocytosis

3.45

3.04

13.9

4.0

—

Enterocolitis due to Clostridium difficile

3.45

3.04

6.8

4.6

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2.87

3.04

5.4

5.7

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

3.13

3.03

2.6

1.2

—

Pneumonia derived septicemia

5.86

3.02

8.3

5.5

—

Immunodeficiency with predominantly antibody defects

10.04

2.98

2.0

6.0

—

Benign neoplasm: Cranial nerves

10.04

2.98

2.0

1.2

—

Lung cancer and mesothelioma

2.93

2.98

2.5

3.4

—

Disorders of other endocrine glands

118

2.09

2.96

6.5

5.3

—

Other retinal disorders

186

1.77

2.94

5.2

5.3

—

Injuries to the hip and thigh

142

1.93

2.88

4.7

5.3

—

Other cataract

103

2.03

2.87

5.4

4.9

—

Atrial fibrillation and flutter with reimbursement

2.54

2.82

3.3

5.5

—

Conductive and sensorineural hearing loss

203

1.67

2.81

4.8

5.6

—

Colonic or urogenital fistula

2.40

2.79

4.7

5.6

—

Cardiovascular diseases (excluding rheumatic etc)

2.29

2.77

5.6

5.5

—

115

2.00

2.75

5.6

5.5

—

Non-follicular lymphoma, hilmo, excluding all cancers

5.01

2.72

2.7

1.2

—

Disorders resulting from impaired renal tubular function

6.02

2.70

8.7

6.8

—

Dental operations

119

1.77

2.69

5.0

4.7

—

Other CVD (FINNGEN)

3.94

2.69

9.0

5.8

—

Fracture of femur

2.16

2.69

4.9

5.2

—

Abnormal results of function studies

4.22

2.67

4.3

4.8

—

Other disorders of ear

214

1.62

2.65

4.7

5.6

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

2.73

2.64

2.5

1.2

—

Diseases of salivary glands

2.79

2.64

4.1

4.2

—

Intestinal infectious diseases

229

1.63

2.59

9.0

4.7

—

Sleep apnoea

209

1.62

2.58

5.3

5.5

—

Glucagon-like peptide-1 (GLP-1) analogues

193

1.71

2.57

4.0

5.9

—

Myeloproliferative diseases (CML excluded)

3.61

2.57

2.4

4.8

—

Disorders of parathyroid gland

2.30

2.57

5.4

6.1

—

Thrombocytopenia, unspecified

4.01

2.56

9.0

4.9

—

L04AD Calcineurin inhibitors

4.00

2.56

6.0

3.8

—

Benign neoplasm of brain and other parts of central nervous system

7.15

2.55

2.0

1.1

—

Acute posthaemorrhagic anaemia

5.47

2.54

5.2

—

Dorsalgia

170

1.62

2.54

6.4

4.7

—

Zoster [herpes zoster]

2.50

2.52

8.7

5.1

—

Chronic laryngitis and laryngotracheitis

3.03

2.52

6.7

4.8

—

Other and unspecified urticaria

3.03

2.52

5.5

6.0

—

Other dorsopathies, not elsewhere classified

170

1.61

2.51

5.3

4.7

—

Conduction disorders

2.23

2.47

2.4

6.5

—

Carcinoma in situ of skin

4.38

2.47

10.9

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

176

1.76

2.47

8.6

4.8

—

Other disorders of lacrimal gland

102

2.06

2.46

9.7

6.0

—

Fall on same level

196

1.57

2.40

5.3

5.8

—

Stomatitis and related lesions

5.01

2.40

2.3

5.3

—

Small fibre neuropathy

6.28

2.37

1.6

5.2

—

Rare circulating lymphoid malignancy

6.27

2.37

8.4

6.8

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

2.15

2.36

5.7

1.4

—

Visual impairment including blindness (binocular or monocular)

3.64

2.36

1.8

4.0

—

Bronchitis, not specified as acute or chronic

3.64

2.36

7.4

5.0

—

Polymyalgia rheumatica

2.61

2.35

5.6

4.4

—

Coagulation defects, purpura and other haemorrhagic conditions

2.61

2.35

8.3

4.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

117

1.95

2.35

5.9

5.7

—

Other disorders of urethra and urinary system

163

1.70

2.35

8.2

5.4

—

Complications of medical and surgical care

231

1.64

2.33

4.2

5.8

—

Sensorineural hearing loss

201

1.60

2.31

4.3

5.6

—

Wet age-related macular degeneration

2.25

2.31

4.3

5.5

—

Myeloproliferative diseases

3.22

2.30

2.4

4.4

—

Phlebitis and thrombophlebitis (not including DVT)

2.37

2.29

7.4

6.2

—

Emergency coronary revascularization (for ACS)

189

0.42

2.28

4.8

5.5

—

Fracture of rib(s), sternum and thoracic spine

2.12

2.28

7.0

4.7

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

218

1.55

2.27

4.7

5.7

—

Preparatory care for dialysis

4.63

2.27

8.7

6.1

—

Immunodeficiencies

4.63

2.27

2.0

4.3

—

Certain disorders involving the immune mechanism

2.56

2.26

6.1

4.6

—

Migraine without aura

3.89

2.25

8.9

5.5

—

Symptoms and signs concerning food and fluid intake

3.89

2.25

2.4

5.6

—

Other disorders of veins

120

1.92

2.24

3.9

6.4

—

Rheumatoid arthritis

1.99

2.23

1.8

6.3

—

Heart failure, strict

170

1.65

2.22

4.0

5.8

—

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

5.56

2.21

3.8

1.1

—

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

5.56

2.21

7.6

1.1

—

Falls/tendency to fall

171

1.55

2.20

5.5

5.9

—

Coronary angioplasty

141

0.38

2.19

4.0

5.6

—

Hydronephrosis

3.34

2.18

3.3

3.8

—

Heart failure and coronary heart disease

128

0.35

2.17

8.7

5.2

—

Degeneration of macula and posterior pole

166

1.69

2.16

5.6

5.0

—

Visual disturbances and blindness

158

1.77

2.16

4.2

5.9

—

Used for control exclusion in common control thyroid runs

166

1.56

2.16

3.8

6.1

—

L01XE Protein kinase inhibitors

3.69

2.15

4.1

5.5

—

Allergic urticaria

4.29

2.15

15.0

5.9

—

Entropion and trichiasis of eyelid

3.00

2.14

7.1

4.0

—

Diseases of the skin and subcutaneous tissue

169

1.54

2.12

6.8

4.7

—

Codeine or tramadol medication

210

1.50

2.11

6.0

5.2

—

Lyme disease

2.21

2.10

4.9

6.1

—

Other spirochaetal diseases

2.21

2.10

4.9

6.1

—

Mycoses

2.21

2.10

5.1

5.3

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

229

1.53

2.10

4.2

5.8

—

Pleural plaque

2.71

2.10

5.2

4.0

—

Cellulitis

2.45

2.10

7.8

4.6

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

3.20

2.09

8.9

1.2

—

Enlarged lymph nodes

3.20

2.09

2.0

6.1

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

3.20

2.09

4.0

1.2

—

Moderate visual impairment, binocular

5.02

2.07

2.0

6.1

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

5.01

2.07

7.6

1.1

—

Benign lipomatous neoplasm of other sites/unspecified

5.00

2.07

6.6

1.1

—

Care involving use of rehabilitation procedures

166

0.40

2.03

2.3

4.7

—

Cardiomyopathy

2.63

2.00

6.5

5.5

—

Candidiasis

2.82

2.00

5.4

4.5

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.11

1.98

5.0

5.6

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

2.29

1.97

5.8

1.4

—

Other medical care

123

1.83

1.97

5.7

4.7

—

Asthma, excluding more controls

1.82

1.97

5.9

3.3

—

Benign neoplasm: Ascending colon

3.34

1.96

4.6

1.3

—

Pain in joint

111

1.73

1.95

6.0

4.5

—

Disorders of lacrimal system

134

1.79

1.94

9.0

5.7

—

Occupational exposure to risk-factors

4.56

1.94

9.2

5.1

—

Residual foreign body in soft tissue

4.55

1.94

10.2

4.5

—

Benign neoplasm of eye and adnexa

4.55

1.94

6.0

1.2

—

Temporomandibular joint disorders

2.96

1.93

9.3

5.8

—

Abnormal involuntary movements

2.73

1.93

3.2

4.4

—

Somatoform disorder

2.73

1.93

8.8

5.8

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

2.73

1.93

7.0

1.2

—

Coronary revascularization (ANGIO or CABG)

160

0.44

1.91

5.2

5.4

—

Other viral diseases

2.44

1.91

13.3

4.5

—

Melanocytic naevi

2.65

1.86

3.8

1.4

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2.39

1.85

5.7

3.9

—

Other symptoms and signs involving the digestive system and abdomen

2.39

1.85

11.3

6.2

—

L04AA Selective immunosuppressants

2.39

1.85

4.7

6.6

—

Fracture of skull and facial bones

2.39

1.85

6.3

5.4

—

Other otitis externa (chronic)

3.54

1.83

4.0

5.5

—

Hypertensive diseases (excluding secondary)

2.01

1.83

4.3

5.5

—

Complications of surgical and medical care, not elsewhere classified

237

1.48

1.83

4.1

5.8

—

Dermatitis due to substances taken internally

4.17

1.82

8.6

4.1

—

Acute pharyngitis

3.51

1.82

11.5

4.1

—

Chronic tubulo-interstitial nephritis

4.18

1.82

6.8

3.6

—

Other symptoms and signs involving the circulatory and respiratory systems

4.17

1.82

10.4

5.2

—

Benign neoplasm of other and unspecified endocrine glands

4.17

1.82

6.4

1.2

—

Diseases of the eye and adnexa

1.69

1.82

5.5

5.0

—

Diseases of the ear and mastoid process

186

1.47

1.81

5.6

5.0

—

Other gastritis (incl. Duodenitis)

2.06

1.80

3.0

5.5

—

Misadventures to patients during surgical and medical care

2.57

1.80

3.6

4.1

—

Superficial injury of thorax

2.57

1.80

10.2

3.6

—

Disorders of continuity of bone

3.05

1.80

3.3

5.2

—

Other metabolic disorders

3.05

1.80

7.0

6.1

—

Suppurative and unspecified otitis media

2.38

1.79

9.5

4.3

—

Neuromuscular dysfunction of bladder

2.76

1.79

2.1

3.2

—

Pain in limb

182

1.55

1.78

6.6

5.4

—

Dental pulpitis 2

127

1.57

1.77

4.2

5.0

—

Pleural effusion

2.34

1.77

3.3

3.9

—

Lymphoid leukaemia

3.34

1.74

10.2

3.8

—

Corns and callosities

3.34

1.74

11.0

5.8

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2.03

1.74

5.1

5.3

—

Cardiovascular diseases

2.08

1.74

6.1

6.0

—

Irritable bowel syndrome

2.22

1.73

8.6

4.4

—

Idiopathic gout

2.67

1.72

5.3

4.6

—

Chalazion

2.92

1.72

4.1

4.5

—

Valvular heart disease excluding rheumatic fever

106

1.72

4.4

6.2

—

Hypoparathyroidism

3.86

1.71

4.4

5.4

—

Generalized skin eruption due to drugs and medicaments

3.86

1.71

8.6

6.2

—

In situ neoplasms

2.14

1.71

9.5

1.3

—

Type of accident

2.06

1.70

5.4

5.3

—

Sleep disorders (combined)

215

1.46

1.68

5.3

5.5

—

Leisure time condition

2.38

1.67

2.5

5.0

—

Ulcer of lower limb, not elsewhere classified

2.38

1.67

6.2

4.7

—

Asthma (only as main-diagnosis)

1.74

1.66

5.7

3.1

—

Hyperplasia of prostate

1.77

1.66

3.1

4.5

—

Abnormalities of heart beat

1.89

1.65

4.1

5.9

—

Vocal cord dysfunction

2.83

1.65

3.4

6.4

—

Pain, not elsewhere classified

2.10

1.65

3.2

5.0

—

Pain associated with micturition

2.80

1.65

6.6

4.0

—

Benign neoplasm: Rectum

2.80

1.65

3.4

1.2

—

Other diseases of the respiratory system

2.03

1.64

1.6

4.8

—

Other respiratory disorders and diseases

2.03

1.64

1.6

4.8

—

Benign neoplasm: Cranial nerves

3.58

1.61

2.0

5.9

—

Acute generalized exanthematous pustulosis

3.58

1.61

8.6

5.9

—

Benign neoplasm of mouth and pharynx

3.57

1.61

2.0

1.2

—

Myalgia

2.14

1.60

7.3

5.5

—

Hypotension

2.14

1.60

8.0

3.5

—

Sleep apnoea, including avohilmo

210

1.45

1.59

5.3

5.5

—

Benzodiazepine use

237

1.44

1.59

5.1

5.6

—

Syncope and collapse

113

1.73

1.58

5.2

4.5

—

Autoimmune diseases related-to ILD

237

1.48

1.58

3.4

6.0

—

Other specific joint derangements/joint disorders

136

1.58

5.3

6.0

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

3.00

1.58

2.7

1.3

—

Glomerulonephritis

2.70

1.58

2.9

4.3

—

Other local infections of skin and subcutaneous tissue

2.70

1.58

8.9

4.6

—

Haemorrhage from respiratory passages

105

1.77

1.57

7.2

5.0

—

Cholelithiasis

211

1.46

1.57

4.8

5.5

—

Other disorders of eyelid

169

1.60

1.56

6.1

5.2

—

Asthma

1.68

1.56

5.9

3.1

—

Pain in throat and chest

139

1.54

5.7

5.4

—

Diseases of middle ear and mastoid

1.74

1.54

7.9

5.3

—

Benign lipomatous neoplasm

2.27

1.53

6.3

1.3

—

Presence of cardiac and vascular implants and grafts

103

1.69

1.51

2.5

4.4

—

Other infectious diseases

2.60

1.51

10.6

4.2

—

Pruritus

2.59

1.51

7.0

3.9

—

Other disorders of conjunctiva

0.00

1.51

0.0

4.4

—

Osteomyelitis

2.86

1.50

2.5

4.5

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

2.86

1.50

9.0

4.0

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

2.86

1.50

8.0

6.2

—

Non-rheumatic valve diseases

105

1.67

1.50

4.5

6.2

—

Lower back pain or/and sciatica

234

1.42

1.50

7.3

5.2

—

Hypothyroidism, strict autoimmune

142

1.54

1.48

5.1

6.3

—

Retention of urine

1.77

1.48

4.1

4.6

—

Leiomyoma of uterus

2.02

1.46

10.1

1.6

—

Traumatic subdural haemorrhage

2.39

1.46

2.0

4.6

—

COPD-related respiratory insufficiency

2.22

1.46

3.8

4.3

—

Other and unspecified dermatitis

155

1.61

1.46

4.8

5.8

—

Injury, poisoning and certain other consequences of external causes

1.65

1.45

4.5

4.9

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

2.37

1.45

4.8

1.4

—

Other external causes of accidental injury

131

1.49

1.45

6.5

5.4

—

TMD related operations

2.50

1.45

6.6

5.1

—

Insulin, intermediate and long-acting

191

1.54

1.45

5.2

5.1

—

Migraine without aura and triptan purchases

3.13

1.44

7.2

6.4

—

Other disorders of nervous system

2.73

1.43

6.3

3.7

—

Neurological diseases

128

1.49

1.43

5.5

5.2

—

Other and unspecified drugs and medicaments

2.73

1.43

9.0

3.5

—

Open wound of forearm

2.73

1.43

4.7

4.4

—

Injuries to the head

233

1.40

1.41

4.7

5.7

—

All-cause Heart Failure

169

1.49

1.41

4.1

5.8

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

2.13

1.40

6.9

1.5

—

Other diseases of urinary system

196

1.41

1.40

6.4

5.3

—

Asthma (mode)

1.63

1.39

6.1

3.1

—

Abnormal weight loss

2.42

1.39

2.4

4.4

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

183

1.45

1.37

5.3

5.8

—

Cerebrovascular diseases (FINNGEN)

1.98

1.37

9.8

5.5

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

2.61

1.36

3.7

4.8

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

2.61

1.36

7.3

1.3

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

2.61

1.36

4.0

1.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.61

1.36

5.2

5.0

—

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

2.61

1.36

8.5

1.3

—

Non-Hodgkin lymphoma, all

2.95

1.36

3.6

4.6

—

Other disorders of white blood cells

2.95

1.36

5.6

5.2

—

Pure hypercholesterolaemia

175

1.46

1.35

5.1

5.0

—

Parodontitis

230

1.41

1.35

4.8

5.8

—

Parodontitis or operation codes

230

1.41

1.34

4.8

5.8

—

Sequelae of cerebrovascular disease

132

1.60

1.34

3.5

5.5

—

1.78

1.32

6.8

4.9

—

Statin medication

147

0.57

1.32

3.9

5.6

—

Other symptoms and signs involving cognitive functions and awareness

157

1.55

1.31

3.5

5.7

—

Conjunctivitis (acute, non atopic)

1.96

1.31

9.3

5.3

—

Osteoporosis with pathological fracture (FG)

2.50

1.30

3.8

7.8

—

Other and unspecified local infections of skin and subcutaneous tissue

2.50

1.30

10.2

4.6

—

Paroxysmal tachycardia

2.11

1.30

3.9

5.6

—

Disorder of lipoprotein metabolism, unspecified

2.09

1.30

10.1

4.6

—

Heart failure and bmi 25plus

109

1.58

1.29

4.6

6.1

—

Vitamin B12 deficiency anaemia

2.35

1.29

1.1

4.6

—

Benign neoplasm of brain and other parts of central nervous system

2.78

1.28

2.0

5.3

—

Persons encountering health services in circumstances related to reproduction

0.42

1.28

7.0

5.6

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

2.78

1.28

3.0

1.3

—

Accidents

131

1.45

1.28

6.6

5.4

—

Otitis externa

2.08

1.27

4.0

5.9

—

Gingivitis and periodontal diseases

144

1.43

1.27

5.4

5.1

—

Diseases of the myoneural junction and muscle

2.29

1.26

7.0

4.3

—

Polycystic ovarian syndrome, consortium definition

110

1.54

1.26

9.0

5.7

—

Asthma (only as main-diagnosis), excluding more controls

1.65

1.24

4.5

3.3

—

Gastroduodenal ulcer

1.74

1.23

3.1

5.5

—

Carbimazole or st.post thyroidectomy, condition for graves disease

2.00

1.23

4.1

7.3

—

Diaphragmatic hernia

139

1.58

1.22

5.4

5.8

—

Gastric ulcer

1.91

1.22

2.8

5.5

—

Dental caries 1 and operation codes

166

1.39

1.22

4.9

5.4

—

Oral lichen ruber planus, including avohilmo

2.64

1.21

4.6

5.0

—

Vascular disorders of the intestines

2.63

1.21

1.2

3.1

—

Dental caries 2 and operation codes

148

1.50

1.21

4.9

6.0

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

2.04

1.21

3.4

1.4

—

Endometriosis of ovary

2.16

1.21

13.0

5.3

—

Insulin medication

181

1.46

1.20

5.1

5.6

—

Paracetamol of NSAID medication

2.24

1.20

7.7

3.3

—

External causes of morbidity and mortality

100

1.50

1.20

4.9

5.6

—

Exposure to other specified factors

192

1.47

1.19

6.6

5.3

—

Other complications of surgical and medical care, not elsewhere classified

2.31

1.18

6.2

5.1

—

Unspecified privation

2.31

1.18

7.5

3.7

—

Budesonide

2.31

1.18

7.5

5.7

—

Spondylopathies (FG)

2.31

1.18

1.3

5.9

—

Chronic periodontitis, including avohilmo

231

1.38

1.18

4.5

5.9

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.74

1.18

3.8

5.1

—

Substance use, excluding alcohol

2.11

1.18

5.8

4.1

—

Viral infections characterized by skin and mucous membrane lesions

109

1.65

1.18

8.8

5.1

—

Persons encountering health services in other circumstances

1.70

1.16

10.5

4.3

—

Cutaneous abscess, furuncle and carbuncle

2.00

1.16

6.8

3.6

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

2.00

1.16

3.9

1.4

—

Disorders of thyroid, IBD co-morbidities

2.60

1.16

4.2

6.3

—

163

1.50

1.15

6.5

5.2

—

Other specified/unspecified bacterial intestinal infections

2.50

1.15

8.8

4.9

—

Paralytic strabismus

2.50

1.15

12.2

5.0

—

Mental and behavioural disorders due to tobacco

2.50

1.15

8.6

5.2

—

Smoking dependency

2.50

1.15

8.6

5.2

—

Thyroiditis, ILD-related definition

2.50

1.15

3.8

6.3

—

Monoamine oxidase A inhibitors

0.00

1.15

0.0

4.7

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

109

1.64

1.15

5.3

5.8

—

Other arrhythmias

132

1.51

1.15

2.8

6.3

—

Rheumatoid arthritis, including avohilmo

134

1.57

1.14

1.8

6.1

—

Nontoxic goitre/thyroid nodule

112

0.45

1.12

3.2

6.3

—

Weight loss

2.34

1.12

2.4

4.3

—

Benign neoplasm: Rectum, anus and anal canal

2.33

1.12

3.4

1.4

—

Infections with a predominantly sexual mode of transmission

2.00

1.12

4.8

5.5

—

Other benign neoplasms of skin

1.84

1.11

4.0

1.4

—

Exposure to unspecified factor

239

1.36

1.11

5.2

5.6

—

Non-follicular lymphoma

2.26

1.10

2.7

4.2

—

Cholelithiasis, broad definition with cholecystitis

217

1.36

1.09

4.9

5.5

—

Decubitus ulcer and pressure area

2.38

1.09

4.2

4.5

—

Other diseases of pancreas

2.38

1.09

1.2

5.4

—

Unspecified urinary incontinence

2.38

1.09

2.2

4.0

—

Other CVD

1.82

1.08

8.0

4.1

—

Diseases of arteries, arterioles and capillaries

199

1.39

1.08

3.5

5.5

—

Adverse effects, not elsewhere classified

2.19

1.08

9.4

4.3

—

Dental caries 1, only avohilmo

161

1.37

1.08

5.4

5.0

—

Dental caries 2

151

1.46

1.07

4.9

5.9

—

Dentofacial anomalies [including malocclusion]

1.93

1.07

9.3

4.7

—

Dental caries 3

157

1.37

1.06

5.5

5.1

—

Carpal tunnel syndrome

182

1.44

1.06

5.6

6.0

—

Dermatitis and eczema

237

1.33

1.06

6.0

5.4

—

Sequelae of injuries, of poisoning and of other consequences of external causes

1.92

1.06

4.7

4.2

—

Benign neoplasms

177

1.36

1.05

5.7

5.0

—

Carcinoma in situ of skin

2.12

1.05

10.9

4.4

—

Excessive attrition of teeth

1.73

1.05

4.5

6.9

—

Other viral diseases, not elsewhere classified

2.12

1.05

13.6

4.5

—

Insulin, combination of fast acting with intermediate-acting or long-acting

202

1.41

1.05

5.1

5.0

—

Hypertension, essential

128

1.43

1.05

4.1

6.6

—

DVT of lower extremities and pulmonary embolism

153

1.50

1.04

8.7

5.3

—

Spirochaetal infections, other/unspecified

2.27

1.03

5.8

4.9

—

Hernia of abdominal wall, postoperative

2.27

1.03

1.4

5.5

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

2.27

1.03

1.6

1.3

—

Dental caries 3 and operation codes

172

1.34

1.02

5.2

5.3

—

Covid-19 suspected case

2.06

1.02

1.6

4.9

—

Endometriosis ASRM stages 3,4

1.88

1.00

11.7

6.1

—

Spondylopathies

169

1.37

1.00

5.2

4.7

—

Other disorders of kidney and ureter

2.00

1.00

7.6

3.9

—

Myocardial infarction, strict

165

0.62

0.98

6.0

5.3

—

Perforation of tympanic membrane

2.18

0.98

2.4

3.7

—

Cardiomyopathies, Primary/intrinsic

2.17

0.98

7.6

3.6

—

Seropositive rheumatoid arthritis

1.71

0.98

1.4

6.2

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

202

1.34

0.98

4.8

5.9

—

Other benign neoplasms of connective and other soft tissue

0.00

0.97

0.0

4.0

—

Hydrocephalus

0.00

0.97

0.0

3.7

—

Cerebral palsy and other paralytic syndromes

0.00

0.97

0.0

4.2

—

Other degenerative diseases of the nervous system

1.65

0.96

3.6

5.0

—

Use of pramipexole

1.74

0.96

6.9

6.2

—

Subjective visual disturbances

1.74

0.96

7.3

6.0

—

Strabismus

1.85

0.96

7.2

5.4

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1.70

0.96

4.5

1.4

—

Any dementia

121

1.46

0.96

3.0

6.0

—

Dental pulpitis 1

195

1.31

0.95

5.9

5.5

—

Diseases of pulp and periapical tissues, including avohilmo

195

1.31

0.95

5.9

5.5

—

Dental pulpitis 4

195

1.31

0.95

5.9

5.5

—

Later onset COPD

1.54

0.95

4.8

5.6

—

Other and unspecified effects of external causes

1.77

0.94

8.1

4.5

—

Delirium, not induced by alcohol and other psychoactive substances

1.89

0.94

5.7

5.3

—

Oral leukoplakia and related diseases, including avohilmo

2.22

0.93

5.7

4.4

—

Dental caries 2, only avohilmo

150

1.42

0.93

5.0

5.9

—

Diseases of liver

101

1.58

0.93

2.9

5.5

—

Type 2 diabetes, wide definition

207

1.32

0.93

4.5

5.8

—

Dorsopathies

170

1.32

0.92

7.3

4.7

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.72

0.92

3.8

5.8

—

Injuries to the shoulder and upper arm

239

1.33

0.92

6.1

5.4

—

Alcoholic liver disease

2.14

0.91

1.2

3.6

—

Sudden idiopathic hearing loss

2.14

0.91

3.0

4.4

—

Benign neoplasm: Sigmoid colon

2.14

0.91

6.2

1.4

—

Hyperparathyroidism

1.75

0.91

6.2

5.9

—

Venous thromboembolism

195

1.39

0.90

7.9

5.4

—

N06DA Anticholinesterases

125

0.58

0.89

2.0

5.6

—

Use of anticholinesterases

125

0.58

0.89

2.0

5.6

—

Other intervertebral disc disorders

169

1.34

0.89

7.2

4.7

—

Myocardial infarction, unclassifiable

0.47

0.89

4.8

4.2

—

Disorders of gallbladder, biliary tract and pancreas

229

1.29

0.88

5.1

5.4

—

Glaucoma

213

0.66

0.88

6.4

5.5

—

Disorders of refraction and accommodation

1.90

0.88

2.9

4.9

—

Anti-inflammatory and antirheumatic products, non-steroids

1.61

0.88

5.0

5.5

—

Use of memantine

1.57

0.88

3.9

4.7

—

Use of other anti-dementia drugs

1.57

0.88

3.9

4.7

—

Other antidepressants

194

1.29

0.87

4.6

5.3

—

Familial hypercholesterolemia

1.79

0.87

9.5

5.1

—

Other noninflammatory disorders of uterus, except cervix

1.67

0.87

7.4

5.1

—

Benign neoplasm: Colon, unspecified

1.61

0.87

5.6

5.8

—

Coeliac disease

2.00

0.87

15.2

3.8

—

Dental caries, including avohilmo

150

1.33

0.87

4.9

5.2

—

Dental caries 1

150

1.33

0.86

4.9

5.2

—

Hypothyroidism, other/unspecified

201

1.31

0.86

4.8

5.9

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

2.00

0.86

2.3

4.3

—

Fracture of lower leg, including ankle

179

0.61

0.85

1.8

6.2

—

Acute and subacute iridocyclitis

1.78

0.84

6.0

4.6

—

Preterm labour and delivery

1.78

0.84

7.9

6.9

—

Dental pulpitis 2, only avohilmo

138

1.34

0.83

4.3

5.0

—

Myocardial infarction

172

0.67

0.83

6.6

5.3

—

Other anxiety disorders

1.66

0.83

4.6

6.2

—

Anterior Iridocyclitis

1.74

0.82

6.0

4.5

—

Episodal and paroxysmal disorders

193

1.27

0.81

6.0

5.2

—

Cystitis

172

1.31

0.80

6.8

5.5

—

Injuries to the elbow and forearm

186

1.36

0.80

5.3

6.0

—

Non-small cell lung cancer

1.73

0.79

2.9

3.8

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

124

0.59

0.79

6.1

5.3

—

Other ill-defined and unspecified causes of mortality

0.00

0.79

0.0

4.2

—

Invasive ventilation

0.00

0.79

0.0

4.7

—

Chronic suppurative otitis media, including avohilmo

0.00

0.79

0.0

4.6

—

Ménière disease

1.82

0.79

8.8

4.4

—

Varicose veins

175

1.34

0.79

5.8

—

Alzheimer’s disease (Atypical or mixed)

1.81

0.79

2.3

5.1

—

Congenital malformations of the circulatory system

0.00

0.78

0.0

4.4

—

Congenital malformations of heart and great arteries

0.00

0.78

0.0

4.5

—

Acute appendicitis, with complications

1.67

0.78

6.0

4.0

—

Injuries to the neck

1.67

0.78

2.4

4.2

—

Vascular dementia

1.81

0.78

1.5

4.7

—

Complications of procedures, not elsewhere classified

231

1.31

0.78

4.9

5.8

—

Reimbursement for rheumatic diseases

181

1.38

0.78

2.4

6.2

—

Other and/or unspecified nontoxic goitre

0.00

0.78

0.0

8.0

—

COPD

149

1.38

0.78

4.0

5.0

—

Malignant neoplasm of bronchus and lung

1.63

0.78

2.6

4.0

—

Diseases of the musculoskeletal system and connective tissue

1.51

0.78

4.3

5.4

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

0.77

0.0

4.5

—

Dental caries 3, only avohilmo

167

1.29

0.77

5.2

5.0

—

Coxarthrosis [arthrosis of hip](FG)

137

1.37

0.77

2.8

5.8

—

Blepharochalasis

115

1.48

0.76

5.6

5.8

—

Seronegative rheumatoid arthritis

1.77

0.76

1.2

7.1

—

Recurring oral aphthae, including avohilmo

1.77

0.76

1.3

4.4

—

conjunctival haemorrhage

0.00

0.76

0.0

4.4

—

Fracture of shoulder and upper arm

107

1.49

0.75

5.6

5.3

—

Effects of foreign body entering through natural orifice

1.70

0.75

4.8

4.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1.57

0.74

1.4

5.9

—

Peripheral artery disease

147

1.37

0.74

3.6

5.7

—

Rotator cuff syndrome

173

0.69

0.74

6.9

5.4

—

Other abnormal uterine and vaginal bleeding

1.62

0.73

6.3

5.1

—

Degenerative macular diseases

1.84

0.73

7.4

3.2

—

Tuberculosis

2.00

0.72

6.0

4.3

—

Seborrhoeic dermatitis

2.00

0.72

3.8

3.3

—

Hypokalaemia

2.00

0.72

2.6

5.4

—

Benign neoplasm: Skin of eyelid, including canthus

2.00

0.72

4.4

1.5

—

Skin changes due to chronic exposure to nonionizing radiation

158

1.38

0.72

6.2

5.2

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

136

0.59

0.72

7.3

4.4

—

Amputation

1.80

0.72

2.4

4.2

—

Abnormal serum enzyme levels

106

0.56

0.72

2.0

5.0

—

Tonsillectomy and adenotomy

1.61

0.72

3.7

4.8

—

Other chronic obstructive pulmonary disease

146

1.37

0.71

4.2

5.0

—

Neurotic, stress-related and somatoform disorders

180

1.30

0.71

6.0

5.6

—

Other diseases of liver

1.75

0.71

2.4

4.0

—

Alzheimer disease, excluding more controls

1.60

0.71

2.8

5.6

—

COPD, hospital admissions

149

1.36

0.71

4.2

5.3

—

Faecal incontinence

1.92

0.70

7.6

7.0

—

Hypertensive diseases

128

1.33

0.70

3.5

6.6

—

Hypertension

128

1.33

0.70

3.5

6.6

—

Open wound of head

166

1.36

0.70

3.1

5.6

—

Visual disturbances

143

1.40

0.69

5.2

6.0

—

Noninfective enteritis and colitis

126

1.43

0.69

4.2

5.3

—

Primary open-angle glaucoma

140

0.63

0.69

7.1

5.7

—

Parodontitis and operation codes

233

1.27

0.68

4.2

5.9

—

Non-small cell lung cancer, adenocarcinoma

1.85

0.68

3.8

4.3

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

1.85

0.68

3.8

4.3

—

Otosclerosis

1.85

0.68

5.4

4.5

—

Stenosis and insufficiency of lacrimal passages

1.85

0.68

4.8

4.0

—

Cardiomyopathy (excluding other)

1.85

0.68

7.6

3.3

—

Ulcerative colitis, NAS

1.85

0.68

6.4

4.3

—

Other diseases of intestine

1.85

0.68

3.6

3.4

—

Other diseases of oesophagus

1.85

0.68

2.4

4.3

—

Benign leiomyoma with endometriosis

1.85

0.68

8.4

1.4

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

1.66

0.68

6.4

5.5

—

Temporomandibular joint disorders, including avohilmo

1.56

0.68

10.8

6.3

—

COPD, early/later onset

150

1.35

0.67

4.2

5.4

—

Actinic keratosis

153

1.37

0.67

6.3

5.4

—

Any dementia, excluding more controls

111

1.38

0.67

3.2

6.1

—

Nerve, nerve root and plexus disorders

239

1.24

0.67

5.4

5.5

—

Psoriasis vulgaris

1.63

0.66

3.7

4.4

—

Chronic lower respiratory diseases

220

1.23

0.66

5.6

5.5

—

Coxarthrosis, primary, with hip surgery

186

1.33

0.66

3.7

5.8

—

Nonsuppurative otitis media

1.80

0.66

10.2

3.6

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

222

1.23

0.66

8.2

4.8

—

Bronchiectasis

1.79

0.66

4.4

5.8

—

Foreign body on external eye

1.79

0.66

5.2

5.1

—

Other/unspecified seropositive rheumatoid arthritis

1.51

0.66

1.4

5.8

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.51

0.66

4.5

5.7

—

Angina pectoris

192

0.74

0.65

5.6

5.5

—

Bleeding

226

1.26

0.65

5.4

5.5

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1.59

0.65

1.1

3.9

—

Other female pelvic inflammatory diseases

1.59

0.65

7.0

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1.60

0.64

9.1

1.6

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1.60

0.64

9.1

1.6

—

Persons encountering health services in other circumstances, wide

226

1.22

0.64

8.8

4.7

—

Acute appendicitis

178

1.32

0.64

5.6

5.2

—

Basal cell carcinoma

192

1.29

0.64

6.6

5.1

—

Speech disturbances, not elsewhere classified

1.73

0.64

1.2

4.8

—

Other inflammation of eyelid

1.72

0.64

3.4

4.0

—

Anxiety disorders

183

1.28

0.64

6.0

5.6

—

Dermatitis

198

1.31

0.63

4.7

5.8

—

Seropositive rheumatoid arthritis, wide

1.49

0.63

1.4

5.7

—

Dementia in Alzheimer disease

1.53

0.63

2.8

4.9

—

Myocardial infarction, without ST-elevation

163

0.68

0.62

8.7

5.0

—

Other and unspecified myopathies

1.67

0.61

9.6

4.2

—

Benign neoplasm of eye and adnexa

1.67

0.61

6.0

4.6

—

Vitreous haemorrhage

1.67

0.61

5.2

4.0

—

Superficial injury of shoulder and upper arm

1.67

0.61

9.0

3.7

—

Colectomy operation

1.60

0.61

6.9

4.4

—

Excessive, frequent and irregular menstruation

1.46

0.61

8.3

4.9

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

0.00

0.60

0.0

5.9

—

Bitten or struck by other mammals

0.00

0.60

0.0

3.9

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

0.60

0.0

5.1

—

Gonarthrosis, primary, with knee surgery

200

0.73

0.60

2.8

5.9

—

Squamous cell neoplasms and carcinomas of the skin

1.57

0.60

4.0

4.3

—

Other skin changes

1.57

0.60

6.8

4.9

—

Ulcerative colitis

1.57

0.60

5.8

4.4

—

Primary angle-closure glaucoma

0.00

0.60

0.0

5.1

—

Glaucoma suspect

141

0.64

0.60

4.9

5.7

—

Malignant neoplasm of respiratory system and intrathoracic organs

1.48

0.59

2.5

4.3

—

Normal-pressure hydrocephalus

0.00

0.59

0.0

5.0

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

0.59

0.0

4.7

—

Pain (limb, back, neck, head abdominally)

121

1.28

0.59

5.5

4.3

—

0.00

0.59

0.0

4.7

—

Benign neoplasm: Descending colon

0.00

0.58

0.0

4.7

—

Malignant neoplasm of colon

1.51

0.58

7.6

4.4

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1.75

0.58

8.5

4.5

—

Dental caries 3 and operation codes, only avohilmo

0.64

0.58

2.6

5.9

—

Other strabismus

1.71

0.57

2.2

5.6

—

Anxiety disorders, excluding more controls

174

1.26

0.57

6.0

6.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

201

1.29

0.57

3.5

6.0

—

Other or unspecified ileus, impaction or obstruction

1.48

0.57

2.8

4.5

—

Recurrent or chronic depression

1.43

0.57

2.5

5.5

—

Inflammatory diseases of prostate (prostatitis)

1.67

0.56

1.2

4.2

—

Symptoms and signs involving the skin and subcutaneous tissue

219

1.27

0.56

5.4

5.8

—

Other and unspecified tonsillitis

1.64

0.56

6.8

3.7

—

Appendicitis, broad definition

193

1.28

0.56

5.4

—

Mixed conductive and sensorineural hearing loss

1.62

0.55

4.3

4.6

—

Open wound of lower leg

1.62

0.55

5.2

4.9

—

Car occupant injured in other and unspecified transport accidents

1.62

0.55

6.7

4.8

—

Diabetic nephropathy, excluding more controls

1.62

0.55

4.3

5.5

—

Artrosis, including avohilmo

182

0.78

0.55

4.0

5.7

—

Other chronic obstructive pulmonary disease, including avohilmo

176

1.28

0.54

4.5

5.4

—

Non-invasive ventilation

1.51

0.54

2.3

6.4

—

Methotrexate

1.58

0.54

1.3

7.2

—

Alcohol use disorder, ICD-based

125

0.64

0.54

7.3

4.4

—

Superficial injury of hip and thigh

1.58

0.54

4.5

4.4

—

Calcific aortic valvular stenosis

123

0.64

0.54

1.1

5.7

—

Calcific aortic valvular stenosis, operated

123

0.64

0.54

1.1

5.7

—

Operations 2 for CAVS

123

0.64

0.54

1.1

5.7

—

Calcific aortic valvular stenosis, diagnosis (helper)

123

0.64

0.54

1.1

5.7

—

Calcific aortic valvular stenosis, including rheumatic fever

123

0.64

0.54

1.1

5.7

—

Other noninfective gastroenteritis and colitis

1.50

0.54

3.0

5.9

—

Major coronary heart disease event

220

0.79

0.54

5.2

5.6

—

Conjunctivitis

185

1.27

0.54

8.3

5.6

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

1.48

0.53

4.3

6.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

189

1.25

0.53

5.5

5.2

—

Colon adenocarcinoma

1.54

0.53

8.5

4.7

—

Other disorders of the musculoskeletal system and connective tissue

1.54

0.53

5.5

3.7

—

Abrasion of teeth

1.44

0.52

3.9

5.9

—

Allergic rhinitis

1.52

0.52

3.8

4.0

—

Basal cell carcinoma, including avohilmo

196

1.25

0.52

6.6

5.2

—

Complications predominantly related to the puerperium

1.50

0.51

9.7

7.0

—

Diabetic nephropathy

1.48

0.51

4.3

4.7

—

Atopic dermatitis

100

1.36

0.50

5.6

6.1

—

Meniscus derangement

140

1.27

0.50

9.4

6.1

—

Atherosclerosis, excluding cerebral and coronary sclerosis

143

1.29

0.50

3.5

5.7

—

Diseases of appendix

196

1.26

0.50

5.4

—

Endometriosis

1.43

0.50

9.5

5.1

—

Open wound of wrist and hand

100

1.39

0.49

4.4

5.2

—

Diabetic retinopathy, strict definition

1.54

0.48

4.9

4.2

—

Inflammatory diseases of female pelvic organs

126

0.72

0.48

7.7

6.4

—

Benign neoplasm: Ascending colon

1.52

0.48

4.6

4.7

—

Propionic acid derivatives

1.41

0.48

5.9

5.5

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.45

0.48

6.4

5.4

—

Intracranial trauma

108

1.31

0.48

3.3

4.8

—

Glucosamine medication

178

0.76

0.47

8.1

5.6

—

Malignant melanoma

1.49

0.47

10.0

4.7

—

Dislocation, sprain and strain of joints and ligaments of knee

154

0.72

0.47

5.8

5.7

—

Malignant neoplasm of skin

204

1.22

0.47

5.8

5.5

—

Dental caries 2 and operation codes, only avohilmo

134

1.25

0.46

5.0

6.4

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

143

1.30

0.46

3.6

5.6

—

Undefined dementia

1.43

0.46

2.6

4.3

—

Disturbances of skin sensation

1.43

0.46

6.9

6.4

—

Ventral hernia

0.62

0.45

7.6

6.1

—

Primary open-angle glaucoma, strict

117

0.68

0.45

7.9

5.7

—

Other symptoms and signs involving the nervous and musculoskeletal systems

118

0.68

0.45

4.6

5.8

—

Unspecified dementia

1.40

0.45

2.6

5.2

—

Alzheimer disease

1.32

0.44

3.4

5.4

—

Haemorrhage in early pregnancy

1.39

0.44

8.4

7.3

—

Unspecified fall

146

1.29

0.44

5.0

5.6

—

Antihypertensive medication - note that there are other indications

1.33

0.44

4.5

6.8

—

Thyrotoxicosis, other and/or unspecified

1.37

0.44

3.9

6.2

—

Extrapyramidal and movement disorders

130

1.31

0.43

2.5

5.5

—

Alcohol use disorder, Swedish definition

162

0.74

0.43

4.9

5.0

—

Dental operations, only avohilmo

144

1.21

0.43

5.4

4.8

—

Deviated nasal septum

1.37

0.43

6.2

5.2

—

Benign lipomatous neoplasm of other sites/unspecified

1.61

0.43

6.6

4.6

—

Malignant neoplasm of breast

126

0.74

0.43

7.9

6.6

—

Poisoning by medicine

1.61

0.43

1.0

4.6

—

Chronic gastritis

104

1.35

0.43

5.6

5.7

—

Supervision of high-risk pregnancy

0.00

0.43

0.0

6.6

—

Mental and behavioural disorders due to alcohol

147

0.73

0.42

6.1

4.8

—

Coxarthrosis, primary

215

1.21

0.42

3.4

5.9

—

Benign neoplasm of mouth and pharynx

1.56

0.42

2.0

4.0

—

Noninfectious colitis NAS

1.56

0.42

4.2

4.4

—

Atrophic disorders of skin

1.56

0.42

4.6

7.5

—

Unstable angina pectoris

153

0.76

0.42

4.2

5.6

—

Iridocyclitis

1.38

0.41

6.0

5.2

—

Alzheimer’s disease (Early onset), excluding more controls

0.00

0.41

0.0

4.9

—

Other problems related to primary support group, including family circumstances

0.00

0.41

0.0

5.6

—

Benign neoplasm of other and unspecified endocrine glands

1.52

0.41

6.4

5.0

—

Diplopia

1.52

0.41

2.2

3.9

—

Pre-eclampsia

1.52

0.41

1.8

7.2

—

Migraine with aura

1.52

0.41

9.0

6.7

—

Antenatal screening

0.00

0.41

0.0

6.1

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

0.00

0.41

0.0

5.1

—

Dislocation, sprain and strain of joint and ligaments of hip

0.00

0.41

0.0

5.3

—

Attention to artificial openings

0.00

0.41

0.0

4.2

—

Cholera

0.00

0.41

0.0

4.1

—

Sequelae of other external causes

0.00

0.41

0.0

5.7

—

Ingrowing nail

0.00

0.41

0.0

5.6

—

Other infective otitis externa

0.00

0.41

0.0

5.7

—

Calcific tendinitis of shoulder

0.00

0.41

0.0

5.3

—

Crohn's disease of small intestine

0.00

0.41

0.0

5.6

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

0.41

0.0

4.7

—

Serous carcinoma of ovary

0.00

0.41

0.0

5.3

—

Benign neoplasm: Kidney

0.00

0.41

0.0

5.4

—

Benign neoplasm: Small intestine

0.00

0.41

0.0

5.4

—

Other/unspecified disorders of vestibular function

0.00

0.41

0.0

5.3

—

Other neurotic disorders

0.00

0.41

0.0

5.3

—

Additional codes for the location of defect, injury or illness

0.00

0.41

0.0

5.4

—

Other and unspecified injuries of lower leg

0.00

0.41

0.0

5.4

—

Ocular pain

0.00

0.41

0.0

5.1

—

LSIL lesion of the cervix uteri

0.00

0.41

0.0

6.1

—

Progressive vascular leukoencephalopathy

0.00

0.40

0.0

4.6

—

Simple and mucopurulent chronic bronchitis

0.00

0.40

0.0

4.8

—

Alzheimer’s disease (Early onset)

0.00

0.40

0.0

4.7

—

Need for other prophylactic measures

0.00

0.40

0.0

5.2

—

Hemiplegia

0.00

0.40

0.0

4.7

—

Impingement syndrome of shoulder

1.39

0.40

8.1

5.7

—

Transport accidents

1.33

0.40

4.4

5.0

—

Malignant neoplasm of kidney, except renal pelvis

1.47

0.40

3.0

4.3

—

Malignant neoplasm of urinary organs

1.47

0.40

3.0

4.3

—

Adenomyosis (Endometriosis of uterus)

1.47

0.40

8.2

5.9

—

Pain in thoracic spine

1.47

0.40

6.8

4.6

—

Peritonsillar abscess

1.47

0.40

6.4

4.0

—

Fracture of forearm

157

1.25

0.40

5.6

5.9

—

Superficial injury of lower leg

1.33

0.40

4.0

5.9

—

Benign neoplasm: Rectosigmoid junction

0.00

0.40

0.0

5.3

—

Malignant neoplasm of ovary

0.00

0.40

0.0

4.8

—

Lesion of sciatic nerve

0.00

0.40

0.0

5.1

—

Benign neoplasm of urinary organs

0.00

0.40

0.0

4.9

—

Inflammatory disease of cervix uteri

0.00

0.40

0.0

5.2

—

Polypectomy (DHB20)

0.00

0.40

0.0

3.9

—

Chronic suppurative otitis media

0.00

0.40

0.0

3.7

—

Sciatica+with lumbago

134

1.28

0.39

7.3

4.9

—

All anxiety disorders

1.30

0.39

3.9

6.1

—

Obesity, other/unspecified

1.41

0.39

3.1

6.6

—

Peripheral arterial reconstruction

1.41

0.39

3.2

4.5

—

Unspecified jaundice

0.00

0.39

0.0

4.4

—

Thyrotoxicosis with toxic multinodular goitre

0.00

0.39

0.0

4.8

—

0.00

0.39

0.0

3.4

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

1.40

0.38

3.8

1.4

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

1.32

0.38

5.7

4.9

—

Dementia, including avohilmo

141

1.22

0.38

2.8

6.0

—

Early onset COPD, excluding more controls

1.39

0.38

1.8

2.9

—

Alzheimer disease, including avohilmo

115

1.26

0.38

3.9

5.3

—

Melanocytic naevi

1.34

0.38

3.8

5.7

—

Acute appendicitis, no complications

133

1.27

0.37

5.4

5.5

—

Other extrapyramidal and movement disorders in other diseases

1.32

0.37

2.7

5.5

—

Inflammatory bowel disease

1.32

0.37

5.3

5.7

—

Striking against or struck by other objects

1.32

0.37

5.2

4.8

—

Malignant neoplasm of breast, HER2-negative

125

0.76

0.37

7.9

6.5

—

Oxicams

1.37

0.37

3.8

5.5

—

Coxarthrosis

133

1.22

0.37

3.0

5.8

—

Other menopausal disorders

0.64

0.37

9.4

4.8

—

Amiodarone users

1.35

0.37

2.8

4.2

—

Duodenal ulcer

1.35

0.37

3.4

4.5

—

Other and unspecified nerve root and plexus disorders, also in other diseases

1.35

0.37

4.2

4.9

—

Functional dyspepsia

1.39

0.36

3.6

5.7

—

Cholecystectomy

227

0.82

0.36

4.0

5.8

—

Dizziness and giddiness

220

1.18

0.36

4.2

5.8

—

Spondyloarthritis

1.43

0.35

1.3

4.8

—

Pre-eclampsia or poor fetal growth

1.42

0.35

1.7

7.3

—

Nontraumatic intracranial haemmorrhage

0.63

0.35

5.6

5.1

—

Parodontitis or/and operation codes

128

1.21

0.35

3.6

6.6

—

Fenamates

1.40

0.35

3.3

6.6

—

Migraine

1.32

0.35

6.9

4.9

—

Familial hypercholesterolemia, with ischemic heart disease

1.40

0.35

4.3

4.2

—

Secondary uncertain malignant neoplasm

1.36

0.34

3.8

4.3

—

Benign mammary dysplasia

1.36

0.34

9.0

7.4

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.34

0.34

6.0

6.7

—

Seropositive rheumatoid arthritis, strict definition

1.33

0.33

1.3

6.7

—

Symptoms and signs involving the digestive system and abdomen

183

1.15

0.33

6.3

5.3

—

Soft tissue disorders

185

1.15

0.33

5.5

5.3

—

Pregnancy with abortive outcome

105

0.80

0.33

4.7

7.2

—

Use of donepezil

0.69

0.33

2.3

4.5

—

Peripheral artery operations in Hilmo

1.30

0.33

2.7

4.0

—

Mood disorders

230

0.86

0.32

4.1

5.8

—

Retinal detachments and breaks

119

1.26

0.31

8.5

4.9

—

Depression

211

0.85

0.31

3.8

5.8

—

Cerebrovascular diseases

224

1.15

0.31

6.1

5.5

—

Ganglion

1.35

0.31

7.6

5.6

—

Major coronary heart disease event excluding revascularizations

211

0.85

0.31

5.5

5.4

—

Unspecified mental disorder

0.73

0.30

3.6

5.8

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.70

0.30

3.0

7.1

—

Mood [affective] disorders

229

0.86

0.30

4.1

5.8

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

193

1.19

0.30

3.1

6.0

—

Biguanides

222

1.14

0.30

3.7

6.0

—

Intracranial injury

169

1.20

0.30

3.1

5.8

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

1.31

0.30

1.7

6.0

—

Fracture at wrist and hand level

1.31

0.29

6.0

5.5

—

Leiomyoma of uterus

112

0.81

0.29

8.9

5.8

—

COPD related to multimorbidity

132

1.21

0.29

3.8

5.4

—

Disorders of lipoprotein metabolism and other lipidaemias

180

1.15

0.29

4.3

5.0

—

Pacemaker

135

1.22

0.29

2.5

5.6

—

Hernia of abdominal wall

151

0.79

0.28

4.3

5.3

—

Internal derangement of knee

116

0.77

0.27

4.4

5.8

—

Disorders of vitreous body and globe

182

1.18

0.27

5.1

5.6

—

Other headache syndromes

113

1.24

0.26

9.9

5.2

—

Asthma (diagnoses ohter than nonallergic)

248

1.14

0.26

6.7

5.3

—

Dental pulpitis 1, only avohilmo

218

0.89

0.26

5.9

5.5

—

Unspecific neurodegenerative disorder

135

1.17

0.26

3.5

5.9

—

Menorrhagia

1.26

0.26

9.8

4.9

—

Nontoxic multinodular goitre

0.68

0.26

3.2

6.0

—

severe traumatic brain injury, does not include concussion

1.25

0.25

2.0

4.1

—

Diseases of male genital organs

1.20

0.25

2.8

4.7

—

Type 2 diabetes, definitions combined, including avohilmo

215

0.88

0.25

5.2

5.9

—

Injuries to the knee and lower leg

244

0.89

0.25

4.5

5.7

—

Colorectal adenocarcinoma

1.22

0.25

7.0

5.0

—

Hyperlipidaemia, other/unspecified

134

1.20

0.25

7.4

5.0

—

Sulfasalazine

1.20

0.25

2.3

5.7

—

Soft tissue disorders related to use, overuse and pressure

1.26

0.24

5.7

6.1

—

Polyarthrosis

1.17

0.24

3.1

6.7

—

Other nutritional deficiencies

176

0.83

0.24

3.0

5.8

—

171

0.84

0.24

4.6

5.2

—

COPD, hospital admissions 1, only main diagnosis

121

1.20

0.24

3.3

5.2

—

Other joint disorders

145

1.14

0.24

4.4

6.0

—

Appendectomy

164

1.17

0.24

5.3

5.7

—

Alcohol dependence

0.71

0.24

1.0

4.5

—

Kela-code for severe mental illness

0.71

0.24

4.0

5.7

—

Disorders of vitreous body

176

1.17

0.23

5.3

5.7

—

Hernia

224

1.12

0.23

5.2

5.8

—

Disorders of the thyroid gland

222

1.12

0.23

5.1

5.7

—

Pre-eclampsia or eclampsia

1.32

0.23

1.8

7.0

—

Poisoning by drugs, medicaments and biological substances

1.32

0.23

1.0

4.2

—

Other diseases of upper respiratory tract

217

1.11

0.23

5.8

5.4

—

5-aminosalicylic acid

1.28

0.23

5.8

6.2

—

Benign paroxysmal vertigo

0.76

0.22

12.0

5.9

—

Obesity and other hyperalimentation

166

0.83

0.22

2.7

5.6

—

Single delivery by caesarean section

0.00

0.22

0.0

5.9

—

Maternal care for other known or suspected fetal problems

0.00

0.22

0.0

6.0

—

Paralytic ileus and intestinal obstruction

1.27

0.22

3.1

4.6

—

Other disorders of bladder

1.22

0.22

2.6

4.3

—

Other endocrine disorders

0.00

0.21

0.0

6.7

—

Abnormal spermatozoa

1.19

0.21

2.2

3.4

—

Retinal breaks without detachment

1.19

0.21

12.4

5.0

—

Achalasia of cardia

0.00

0.21

0.0

6.2

—

Disorders of optic nerve, not elsewhere classified

0.00

0.21

0.0

6.1

—

Carcinoma in situ of skin of scalp and neck

0.00

0.21

0.0

5.5

—

Benign neoplasm: Duodenum

0.00

0.21

0.0

5.7

—

Prurigo nodularis

0.00

0.21

0.0

4.5

—

Other and unspecified diseases of blood and blood-forming organs

0.00

0.21

0.0

6.6

—

Adenocarcinoma of pancreas

0.00

0.21

0.0

5.9

—

Inguinal of femoral hernia, unilateral

0.00

0.21

0.0

6.6

—

Femoral hernia, unilateral

0.00

0.21

0.0

6.6

—

Inguinal hernia, unilateral

0.00

0.21

0.0

6.6

—

Carcinoma in situ, bladder

0.00

0.21

0.0

3.6

—

Postprocedural disorders of digestive system, not elsewhere classified

0.00

0.21

0.0

4.1

—

Systemic lupus erythematosus, unspecified

0.00

0.21

0.0

6.5

—

Burn and corrosion of trunk

0.00

0.21

0.0

6.6

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

0.00

0.21

0.0

5.4

—

Benign neoplasm: Conjunctiva

0.00

0.21

0.0

7.1

—

Benign neoplasm: Larynx

0.00

0.21

0.0

5.3

—

Other and unspecified corneal deformities and disorders

0.00

0.21

0.0

7.1

—

SLE, strict definition

0.00

0.21

0.0

6.5

—

SLE, ICD10

0.00

0.21

0.0

6.5

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

0.00

0.21

0.0

6.2

—

Other other unspecified disorders of the circulatory system

0.00

0.21

0.0

4.4

—

Systemic lupus erythematosus

0.00

0.21

0.0

7.1

—

Toxic effect of contact with venomous animals

0.00

0.21

0.0

3.8

—

Spinal enthesopathy

0.00

0.21

0.0

3.0

—

Melanocytic naevi of lower limb, including hip

0.00

0.21

0.0

6.9

—

Atopic conjunctivitis

0.00

0.21

0.0

7.3

—

Contusion of other and unspecified parts of foot

0.00

0.21

0.0

6.5

—

Impotence

0.00

0.21

0.0

4.2

—

Episcleritis

0.00

0.21

0.0

7.3

—

Contact with heat and hot substances

0.00

0.21

0.0

6.0

—

Crohn's disease of large intestine

0.00

0.21

0.0

6.5

—

Hypertrophic scar

0.00

0.21

0.0

6.2

—

Inflammatory disorders of breast

0.00

0.21

0.0

6.5

—

Crohn disease (strict definition, require KELA, min 2 HDR)

0.00

0.21

0.0

6.5

—

Crohn disease (strict definition, require KELA)

0.00

0.21

0.0

6.5

—

Focal brain injury

0.00

0.21

0.0

3.2

—

Excessive vomiting in pregnancy

0.00

0.21

0.0

4.5

—

Other benign neoplasms of connective and other soft tissue

0.00

0.21

0.0

1.1

—

Congenital malformations of genital organs

0.00

0.21

0.0

6.6

—

Eating disorders

0.00

0.21

0.0

7.2

—

Other neurological diseases

222

1.12

0.21

7.2

5.3

—

Carcinoma in situ of other and unspecified digestive organs

0.00

0.21

0.0

6.1

—

Chronic lymphocytic leukaemia

0.00

0.21

0.0

5.9

—

Benign neoplasm: Anus and anal canal

0.00

0.21

0.0

6.1

—

Benign neoplasm of other and unspecified sites

0.00

0.21

0.0

5.8

—

Other secondary coxarthrosis

0.00

0.21

0.0

5.8

—

Polyarthritis, unspecified

0.00

0.21

0.0

6.5

—

Other and unspecified iridocyclitis

0.00

0.21

0.0

6.8

—

Other and unspecified coagulation defects

0.00

0.21

0.0

4.3

—

Hypertrophic disorders of skin

0.00

0.21

0.0

6.4

—

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.00

0.21

0.0

6.1

—

Recurrent dislocation and subluxation of joint

0.00

0.21

0.0

6.5

—

Vascular dementia (undefined)

0.00

0.21

0.0

5.1

—

Rheumatism, unspecified

1.16

0.21

3.2

5.7

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

133

1.18

0.21

7.4

5.6

—

Redundant prepuce, phimosis and paraphimosis

1.16

0.21

1.0

5.1

—

Pterygium

0.00

0.21

0.0

5.8

—

Carcinoma in situ of other and unspecified sites

0.00

0.21

0.0

3.5

—

Malignant neoplasm of oral cavity

0.00

0.21

0.0

5.7

—

Nontoxic diffuse goitre

0.00

0.21

0.0

5.6

—

Chronic hepatitis, not elsewhere classified

0.00

0.21

0.0

6.3

—

Benign neoplasm: Skin, unspecified

0.00

0.21

0.0

6.3

—

Herpesviral keratitis and keratoconjunctivitis

0.00

0.21

0.0

5.7

—

Disorders of orbit

0.00

0.21

0.0

6.3

—

Atypical facial pain

0.00

0.21

0.0

6.4

—

Radial styloid tenosynovitis [de Quervain]

0.00

0.21

0.0

5.2

—

Congenital malformations of the urinary system

0.00

0.21

0.0

5.7

—

Etanercept

0.00

0.21

0.0

4.3

—

Foreign body or object entering through skin

0.00

0.21

0.0

5.8

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.00

0.21

0.0

5.5

—

Alcohol-induced chronic pancreatitis

0.00

0.21

0.0

5.1

—

Hypermetropia

0.00

0.21

0.0

5.8

—

Delivery

0.77

0.20

4.2

6.4

—

Congenital malformations of cardiac septa

0.00

0.20

0.0

6.3

—

Adenocarcinoma and ductal carcinoma of pancreas

0.00

0.20

0.0

4.9

—

Malignant neoplasm of liver and intrahepatic bile ducts

0.00

0.20

0.0

6.0

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

0.20

0.0

5.9

—

Scleritis and episcleritis

0.00

0.20

0.0

5.9

—

Nonspecific lymphadenitis

0.00

0.20

0.0

5.9

—

Other specified and unspecified personality disorders

0.00

0.20

0.0

6.1

—

Fracture of foot, except ankle

1.25

0.20

9.7

4.9

—

Degenerative diseases of the nervous system

109

1.17

0.20

3.4

5.3

—

Septal defects

0.00

0.20

0.0

5.9

—

Obesity

164

0.85

0.20

2.7

5.7

—

Anxiety (asthma-related co-morbidities)

107

1.18

0.20

3.9

5.9

—

GI-bleeding

115

0.78

0.20

4.3

5.0

—

Thoracic aortic aneurysm

1.20

0.19

4.0

5.1

—

Spondylosis

157

1.15

0.19

5.3

4.9

—

Disorders of conjunctiva

201

1.12

0.19

8.3

5.5

—

Focal epilepsy

1.18

0.19

3.7

4.2

—

Other fall from one level to another

1.15

0.19

6.5

4.1

—

Primary coxarthrosis, bilateral

118

1.19

0.19

4.2

6.0

—

Fall on same level involving ice and snow

184

1.14

0.19

3.3

6.1

—

Chronic diseases of tonsils and adenoids

146

1.13

0.19

5.9

—

Abdominal and pelvic pain

183

1.10

0.19

6.7

5.3

—

Enthesopathies of lower limb, excluding foot

1.13

0.18

3.8

4.4

—

Benign neoplasm: Rectum

1.17

0.17

3.4

5.5

—

Cardiodefibrillation

142

0.84

0.17

6.2

5.1

—

Dental pulpitis 4, only avohilmo

217

0.91

0.17

5.7

5.6

—

Colorectal cancer

1.21

0.17

6.6

5.4

—

Organic, including symptomatic, mental disorders

154

1.12

0.17

3.5

5.6

—

Other maternal disorders predominantly related to pregnancy

0.83

0.17

6.6

7.1

—

Gonarthrosis [arthrosis of knee](FG)

148

1.11

0.17

5.1

5.9

—

Alzheimer’s disease, wide definition

1.19

0.17

3.1

4.9

—

Early onset COPD

0.72

0.16

1.8

4.8

—

Mouth breathing

120

0.83

0.16

5.6

5.4

—

Alzheimer’s disease, wide definition, excluding more controls

1.16

0.16

4.0

5.3

—

Epilepsy

1.22

0.16

6.1

4.7

—

Myocardial infarction, with ST-elevation

1.16

0.16

6.6

3.9

—

Triptan medication for migraine, min. 3 purchases

1.18

0.15

5.8

5.9

—

Any mental disorder

204

1.08

0.15

4.8

5.7

—

Hallux valgus (acquired)

1.16

0.15

6.8

6.3

—

Insulin, fast-acting

102

1.18

0.15

6.5

5.0

—

Voice disturbances

1.11

0.15

3.6

5.4

—

Transient ischemic attack

185

0.90

0.14

7.1

5.1

—

Bacterial pneumoniae

1.16

0.14

8.5

3.4

—

Postmenopausal bleeding

0.80

0.14

4.3

5.0

—

Substance abuse

173

0.88

0.14

6.9

5.0

—

166

0.88

0.14

4.6

5.3

—

L02BG Aromatase inhibitors

100

0.80

0.13

8.4

6.5

—

Combinations of oral blood glucose lowering drugs

100

0.80

0.13

4.5

5.8

—

Delivery, wide proxy

0.83

0.13

4.2

7.0

—

Allergic conjunctivitis

139

1.13

0.13

7.4

5.8

—

Disorders of synovium and tendon

153

1.12

0.13

4.0

5.6

—

Lumbar disc prolapse

158

1.11

0.13

9.2

4.8

—

Aortic aneurysm

1.18

0.13

3.5

4.6

—

Arthrosis

145

0.91

0.13

3.0

6.0

—

Injuries to the ankle and foot

154

0.89

0.12

6.5

5.4

—

Other arthrosis

136

0.89

0.12

4.8

6.2

—

COPD, hospital admission 2, with asthma infections

105

1.14

0.12

5.7

5.6

—

Alzheimer’s disease (Late onset)

1.16

0.12

3.3

5.0

—

Coxibs

1.17

0.12

2.4

5.5

—

Irregular menses

1.18

0.12

11.3

5.7

—

Benign neoplasm: Colon

206

1.09

0.11

6.1

5.6

—

Congenital malformations, deformations and chromosomal abnormalities

131

0.88

0.11

4.3

5.9

—

Single spontaneous delivery

0.86

0.11

3.9

6.4

—

Disorders of breast

124

1.12

0.11

9.0

6.4

—

Disorders of vestibular function (Vertigo)

166

0.90

0.11

7.8

5.7

—

Non-selective monoamine reuptake inhibitors

130

1.12

0.10

7.9

5.6

—

Mood disorders, excluding more controls

196

0.93

0.10

4.1

5.7

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

212

1.07

0.10

5.0

6.0

—

Cholecystitis

1.14

0.10

2.2

4.0

—

Abdominal aortic aneurysm (AAA)

1.13

0.10

2.6

3.8

—

Asthma-related pneumonia

125

1.12

0.10

9.1

5.1

—

Asthma-related pneumonia or sepsis

125

1.12

0.10

9.1

5.1

—

Asthma, hospital admissions 3, pneumonia

125

1.12

0.10

9.1

5.1

—

Other disorders of the genitourinary system

1.11

0.09

8.0

6.7

—

Benign neoplasm of colon, rectum, anus and anal canal

227

1.07

0.09

5.7

5.5

—

Obesity due to excess calories

114

0.88

0.09

1.3

6.2

—

L02BA Anti-estrogens

1.06

0.09

7.4

6.9

—

Focal epilepsy, strict definition

1.06

0.09

4.2

3.9

—

Dysphagia

1.15

0.09

2.5

5.1

—

Other enthesopathies

1.15

0.09

9.4

5.4

—

Parkinson's disease, excluding more controls

1.06

0.09

1.6

5.5

—

Benign neoplasm: Skin of eyelid, including canthus

1.04

0.09

4.4

5.2

—

Diseases of the digestive system

164

1.09

0.09

8.8

4.9

—

Endocrine, nutritional and metabolic diseases

118

1.08

0.09

4.0

5.6

—

Lichen planus, including avohilmo

1.11

0.09

3.7

6.3

—

Diseases of inner ear

190

1.08

0.08

8.3

5.7

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.05

0.08

2.3

5.2

—

Insulin, fast-acting or short human

107

1.12

0.08

6.5

5.3

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

0.83

0.08

10.0

6.2

—

Diabetic retinopathy, excluding more controls

1.07

0.08

7.6

5.1

—

Schizophrenia, schizotypal and delusional disorders

0.77

0.08

12.6

4.9

—

116

1.11

0.08

11.9

4.9

—

Adjustment and management of implanted device

1.09

0.08

1.4

4.8

—

Thyrotoxicosis

1.06

0.08

3.9

6.1

—

Dental caries 1 and operation codes, only avohilmo

0.88

0.08

3.6

6.1

—

Noninflammatory disorders of female genital tract

0.88

0.07

5.4

4.9

—

Triptan medication for migraine, single purchase ok

132

0.92

0.07

6.3

6.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

132

0.92

0.07

6.3

6.1

—

Umbilical hernia

0.80

0.07

2.0

5.4

—

Psoriasis

1.08

0.07

3.4

5.4

—

Deforming dorsopathies

1.08

0.07

3.9

5.4

—

Bacterial pneumonia (organism specified)

149

0.92

0.07

9.1

4.8

—

Disorders of skin appendages

112

0.89

0.07

6.9

5.4

—

Complications of labour and delivery

1.09

0.07

6.5

6.8

—

Diabetes medication

220

1.05

0.07

4.2

5.9

—

Fibroblastic disorders

0.87

0.07

7.4

5.2

—

Artificial joint operation, meniscal resection

241

1.05

0.07

5.6

—

Hypertensive Heart Disease

1.07

0.07

2.1

7.0

—

Ovarian cyst

0.84

0.07

9.9

5.0

—

Stroke, including SAH

203

1.06

0.07

7.5

5.1

—

Mental and behavioural disorders due to psychoactive substance use

173

0.93

0.06

6.5

5.0

—

Bacterial pneumonia, not elsewhere classified

1.11

0.06

9.2

3.4

—

Symptoms and signs involving speech and voice

1.11

0.06

3.1

5.5

—

Other hearing loss

102

0.87

0.06

4.0

5.7

—

Cervical disc disorders

111

0.90

0.06

5.1

5.0

—

STROKE

157

1.06

0.06

9.5

5.9

—

Other and unspecified disorders of vitreous body

151

0.92

0.06

6.0

5.6

—

Gonarthrosis,primary

236

0.96

0.05

5.8

5.6

—

Benign lipomatous neoplasm

1.11

0.05

6.3

5.4

—

Spinal stenosis

155

1.06

0.05

2.8

4.6

—

Pregnancy, childbirth and the puerperium

0.90

0.05

3.8

7.7

—

Medicines for HER+ breast cancer

117

0.92

0.05

6.9

6.7

—

Primary gonarthrosis, bilateral

185

0.95

0.04

3.3

5.8

—

Concussion

104

1.08

0.04

3.8

4.8

—

Shoulder lesions

179

0.96

0.04

7.4

5.4

—

Type 2 diabetes, definitions combined

213

1.04

0.04

4.8

5.9

—

Disorders of sclera, cornea, iris and ciliary body

160

1.06

0.04

4.2

5.7

—

Diabetes, varying definitions

214

1.03

0.03

5.0

5.9

—

Ischemic heart diseases

212

1.03

0.03

6.1

5.7

—

Malignant neoplasm of breast, HER-positive

117

0.93

0.03

6.9

6.7

—

Ischaemic heart disease, wide definition

212

1.03

0.03

6.1

5.7

—

Hypertensive heart and/or renal disease

1.09

0.03

2.5

6.9

—

Selective serotonin reuptake inhibitors

194

1.03

0.03

4.9

5.3

—

Medical abortion

103

0.95

0.03

4.8

7.3

—

Asthma, hospital admissions , main diagnosis only

242

1.04

0.03

5.3

5.6

—

Type 2 diabetes

214

0.97

0.03

4.9

5.9

—

Other diseases of the digestive system

118

0.93

0.02

6.6

5.0

—

Diabetes mellitus

215

1.03

0.02

5.0

5.9

—

Sulfonylureas

142

0.96

0.02

3.8

5.9

—

Coronary atherosclerosis

199

0.97

0.02

4.2

5.6

—

Hard cardiovascular diseases

219

1.03

0.02

5.8

5.6

—

Exclusions for E4_PCOS_CONSORTIUM

124

0.96

0.02

9.5

5.3

—

Ischaemic Stroke, excluding all haemorrhages

183

1.03

0.01

7.9

5.1

—

Type 2 diabetes, strict (exclude DM1)

216

1.02

0.01

4.8

5.9

—

Asthma/COPD (KELA code 203)

220

1.02

0.01

4.7

5.5

—

Pulmonary heart disease, diseases of pulmonary circulation

116

0.95

0.01

11.7

5.3

—

Urolithiasis

104

1.06

0.01

4.2

4.7

—

In situ neoplasms

124

1.05

0.00

9.5

5.3

—

Symptoms and signs involving the nervous and musculoskeletal systems

196

0.97

0.00

4.0

6.0

—

Other (not insulin) diabetes medications

219

1.02

0.00

3.6

6.0

—

Dementia

134

1.03

0.00

2.8

5.9

—

Asthma, hospital admission 2, infections

181

0.98

0.00

8.9

5.5

—

Asthma-related infections

181

0.98

0.00

8.9

5.5

—

Psychiatric diseases

202

0.99

0.00

4.7

5.6

—

Diabetes, insulin treatment (Kela reimbursement)

229

1.01

0.00

4.9

5.8

—

Headache

120

0.97

0.00

7.6

5.2

—

Stroke, excluding SAH

193

1.00

0.00

7.9

5.2

—

Depression or dysthymia

143

0.98

0.00

3.2

5.2

—

Gonarthrosis

143

1.00

0.00

4.3

6.0

—

Inguinal hernia

145

0.98

0.00

2.4

5.5

—

Female genital prolapse

1.03

0.00

5.6

4.9

—

Acetic acid derivatives and related substances

1.04

0.00

3.2

5.5

—

Substance abuse, excluding more controls

142

0.99

0.00

6.9

5.4

—

Spontaneous abortion

0.97

0.00

3.8

7.3

—

Injuries to the wrist and hand

233

1.00

0.00

5.5

5.6

—

malignant neoplasm of male genital organs

110

0.98

0.00

4.4

4.0

—

Intestinal stricture

105

1.05

0.00

3.5

5.6

—

Calculus of kidney and ureter

1.04

0.00

4.4

—

Keratitis

1.04

0.00

2.5

5.5

—

Other benign neoplasms of skin

124

0.97

0.00

4.0

5.4

—

Pulmonary heart disease

104

0.96

0.00

12.8

4.8

—

Arthropathies

145

0.98

0.00

3.2

6.0

—

Obesity related asthma

102

0.98

0.00

6.1

5.4

—

Diabetic retinopathy

0.99

0.00

5.6

4.0

—

Pulmonary embolism

103

0.97

0.00

12.8

4.8

—

Malignant neoplasm of prostate

110

0.98

0.00

4.4

4.0

—

Papulosquamous disorders

118

1.02

0.00

3.1

5.9

—

Malignant neoplasm of digestive organs

158

1.00

0.00

5.4

5.0

—

Injury of muscle and tendon at shoulder and upper arm level

121

0.99

0.00

4.6

5.1

—

Asthma, including avohilmo

244

1.00

0.00

6.0

5.4

—

Bicuspidal aortic valve syndrome

0.00

0.0

5.0

—

Graves ophthalmopathy, strict

0.00

0.0

10.0

—

Injury of nerves at wrist and hand level

0.00

0.0

5.8

—

Tuberculosis of other organs

0.00

0.0

8.1

—

SLE (Finngen)

0.00

0.0

8.1

—

Erosion and ectropion of cervix uteri

0.00

0.0

3.7

—

Effects of other external causes

0.00

0.0

5.8

—

Prolonged pregnancy

0.00

0.0

9.7

—

Degeneration of nervous system due to alcohol

0.00

0.0

4.2

—

Malignant neoplasm of cervix uteri

0.00

0.0

8.8

—

Burns and corrosions of multiple and unspecified body regions

0.00

0.0

10.0

—

Disorders of speech understanding and production

0.00

0.0

8.7

—

Fourth [trochlear] nerve palsy

0.00

0.0

7.8

—

Cyst of Bartholin Gland

0.00

0.0

5.9

—

Optic neuritis

0.00

0.0

7.4

—

Speech and linguistic disorders

0.00

0.0

7.6

—

Polyp of the female genital tract

0.94

0.00

9.4

4.9

—

Contracture of joint

0.00

0.0

7.3

—

Degeneration of the brain due to alcohol

0.00

0.0

4.2

—

Parkinson's disease, including avohilmo

0.91

0.00

1.6

4.3

—

Ovarian dysfunction

0.00

0.0

5.2

—

Struck by thrown, projected or falling objec

0.00

0.0

7.3

—

Other articular cartilage disorders

0.00

0.0

8.2

—

Disorders of eyelid in diseases classified elsewhere

0.00

0.0

6.9

—

Certain conditions originating in the perinatal period

0.00

0.0

6.4

—

Exposure to smoke, fire and flames

0.00

0.0

8.7

—

Anorexia (incl.atypical)

0.00

0.0

10.2

—

Viral agents as the cause of diseases classified to other chapters

0.00

0.0

5.8

—

Graves ophthalmopathy

0.00

0.0

8.6

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS